Geron Stock Quote GERN - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

2.90

Bid

2.90

Ask

2.93

Volume

8,638,184

2.85 Day's Range 2.985

1.64 52 Week Range 5.34

Market Cap

1.753B

Previous Close

2.92

Open

2.92

Last Trade

2.93

Last Trade Time

Financial Volume

$ 25,080,710

VWAP

2.9035

Average Volume (3m)

10,562,265

Shares Outstanding

604,501,016

Dividend Yield

PE Ratio

-9.49

Earnings Per Share (EPS)

-0.3

Revenue

237k

Net Profit

-184.13M

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's leading drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a ... Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's leading drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses global rights to this drug. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.geron.com

Headquarters

Wilmington, Delaware, USA

Founded

Geron Corp is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GERN. The last closing price for Geron was $2.92. Over the last year, Geron shares have traded in a share price range of $ 1.64 to $ 5.34.

Geron currently has 604,501,016 shares outstanding. The market capitalization of Geron is $1.77 billion. Geron has a price to earnings ratio (PE ratio) of -9.49.

Form 8-K - Current report

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 4 - Statement of changes in beneficial ownership of securities

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted non-statutory stock options to purchase an aggregate of 72,000 shares of Geron...

Geron Announces Positive CHMP Opinion for RYTELO™ (imetelstat) for the Treatment of Adults with Transfusion-Dependent Anemia due to Lower-Risk MDS

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that the Committee for Medicinal...

Geron Announces New IMerge Analyses Presented at ASH Suggesting Clinical Activity of RYTELO™ (imetelstat) in Patients with Lower-Risk MDS Regardless of Type or Number of Prior Therapies

Analyses pooling data from IMerge Phase 2, Phase 3 and the QTc substudy suggest patients who were ESA ineligible or who had prior treatment with luspatercept or lenalidomide experienced clinical...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.54	-15.6976744186	3.44	3.45	2.8	13240628	3.02112832	CS
4	-0.74	-20.3296703297	3.64	3.685	2.8	15841714	3.32510693	CS
12	-1.08	-27.135678392	3.98	4.46	2.8	10562265	3.70301749	CS
26	-1.9986	-40.7994120769	4.8986	4.92	2.8	9445612	4.09326574	CS
52	0.94	47.9591836735	1.96	5.34	1.64	10631895	3.72156138	CS
156	1.73	147.863247863	1.17	5.34	0.9899	6801363	3.09177853	CS
260	1.44	98.6301369863	1.46	5.34	0.75	5386206	2.74046787	CS

GERN - Frequently Asked Questions (FAQ)

What is the current Geron share price?

The current share price of Geron is $ 2.90

How many Geron shares are in issue?

Geron has 604,501,016 shares in issue

What is the market cap of Geron?

The market capitalisation of Geron is USD 1.77B

What is the 1 year trading range for Geron share price?

Geron has traded in the range of $ 1.64 to $ 5.34 during the past year

What is the PE ratio of Geron?

The price to earnings ratio of Geron is -9.49

What is the cash to sales ratio of Geron?

The cash to sales ratio of Geron is 7.23k

What is the reporting currency for Geron?

Geron reports financial results in USD

What is the latest annual turnover for Geron?

The latest annual turnover of Geron is USD 237k

What is the latest annual profit for Geron?

The latest annual profit of Geron is USD -184.13M

What is the registered address of Geron?

The registered address for Geron is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Geron website address?

The website address for Geron is www.geron.com

Which industry sector does Geron operate in?

Geron operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BTCTBTC Digital Ltd	$ 8.2697 (73.73%)	61.45M
BDMDBaird Medical Investment Holdings Ltd	$ 8.80 (62.36%)	18.63M
CRKNCrown Electrokinetics Corporation	$ 0.1235 (54.96%)	764.86M
NUKKNukkleus Inc	$ 29.97 (45.98%)	19.09M
GSITGSI Technology	$ 3.97 (44.36%)	87.7M
DOGZDogness International Corporation	$ 18.23 (-58.77%)	740.45k
ORKTOrangeKloud Technology Inc	$ 3.02 (-24.88%)	21.08M
PMAXPowell Max Ltd	$ 0.6364 (-23.31%)	4.17M
LGCBLinkage Global Inc	$ 0.2876 (-22.27%)	890.66k
YYAIConnexa Sports Technologies Inc	$ 0.8299 (-20.20%)	602.48k
CRKNCrown Electrokinetics Corporation	$ 0.1235 (54.96%)	764.86M
GCTKGlucoTrack Inc	$ 0.0852 (15.45%)	465.22M
RIMEAlgorhythm Holdings Inc	$ 0.0406 (-4.02%)	387.23M
TGLTreasure Global Inc	$ 0.2459 (14.75%)	267.1M
NVDANVIDIA Corporation	$ 137.71 (3.10%)	201.4M